Acute coronary syndrome

There are 519 papers on acute coronary syndrome in aging research: 52 trials and 354 observational studies in people, 1 in cells, 97 reviews.

Disease

519 papers study it208 more mention it90 findings

MeSH

121 new papers in 30 daysSee all 727 papers on acute coronary syndrome

“Participants in the iECG care group were less likely to have an acute coronary syndrome event during the follow-up period than in the RC group (10 vs. 21, P = 0.044; ).”
Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF studyEuropean heart journal open2023doi:10.1093/ehjopen/oead047
  • Human trial52
  • Humans354
  • Cells1
  • In silico4

Interventions

4

GLP-1 receptor agonists

no changein humans1HR 0.83

1 study
  1. GLP-1 receptor agonists were not clearly linked with acute coronary syndrome in humans (Type 2 diabetes and HR+/HER2-negative metastatic breast cancer receiving CDK4/6 inhibitors) (HR 0.83, 95% CI 0.56-1.236).

    “No statistically significant difference was noted for VTE (HR 0.65 95% CI 0.39-1.09, p=0.098), arrhythmia (HR 0.77, 95% CI 0.5-1.2, p=0.245), or ACS (HR 0.83, 95% CI 0.56-1.236, p=0.341).”

    HumansType 2 diabetes and HR+/HER2-negative metastatic breast cancer receiving CDK4/6 inhibitors5 yearsfemales

    Glucagon-Like Peptide 1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Receiving Cyclin Dependent Kinase 4/6 Inhibitors Therapy for Metastatic Breast Cancer

    AHA Scientific Sessions 2026 abstract

More on GLP-1 receptor agonists

Melatonin

no changein humans1

1 study
  1. Melatonin was not clearly linked with acute coronary syndrome in humans (0.55% vs. 0.56%, sRR 0.98 [0.89-1.06]).

    “ACS (0.55% vs. 0.56%, sRR 0.98 [0.89-1.06])”

    Humans5-year

    Melatonin may be linked to slightly higher irregular heartbeat risk

    ESC Congress 2026 abstract

More on Melatonin

Favorable environmental exposures

no changein humans1

1 study
  1. Favorable environmental exposures were not clearly linked with acute coronary syndrome in humans among the ACS-free cohort (p-for-interaction=.09).

    “no such association was observed among the ACS-free cohort (p-for-interaction=.09; Table).”

    Humansamong the ACS-free cohort

    Association of Multiple Environmental Exposures and Acute Coronary Syndrome Outcomes

    ESC Congress 2026 abstract

More on Favorable environmental exposures

Ramadan fasting

no changein humans1

1 study
  1. Ramadan fasting was not clearly linked with acute coronary syndrome in humans (multivariate analysis, overall cohort).

    “According to the results of the multivariate analysis, the period of Ramadan is not associated with increase of risk of SCA”

    Humansmultivariate analysis, overall cohort

    The risk of acute coronary syndrome in Ramadan

    La Tunisie medicale

More on Ramadan fasting

Effects

3

Mortality

upin humans1

1 study
  1. Acute coronary syndrome increases mortality in humans (compared with men).

    “Women with ACS also have longer treatment delays, receive fewer invasive interventions, and have higher mortality rates.”

    Reviewcompared with menfemales

    Sex Differences in the Bidirectional Associations of Psychological Distress and Acute Coronary Syndrome

    Cardiology clinics

Physical function

downin humans1

1 study
  1. Acute coronary syndrome is linked with worse physical function in humans (hospitalized for ACS) (Barthel: 71.2±11.3, p<0.001; Lawton: 4.8±2.5, p=0.02).

    “At 30 days, a significant functional decline was observed (Barthel: 71.2±11.3, p<0.001; Lawton: 4.8±2.5, p=0.02), which persisted at one year.”

    Humanshospitalized for ACS30 daysn = 110

    Detrimental impact of acute coronary syndrome on the independence of the elderly

    Archivos peruanos de cardiologia y cirugia cardiovascular

Telomerase activity

downin humans1

1 study
  1. Acute coronary syndrome is linked with lower telomerase activity in humans (compared with healthy donors).

    “Compared to healthy donors, ACS patients demonstrated the lowest telomerase activity in both CD4+CD28+and CD4+CD28null T cells.”

    Humanscompared with healthy donorsCD4+CD28+ and CD4+CD28null T cells

    Premature CD4⁺ T Cells Senescence Induced by Chronic Infection in Patients with Acute Coronary Syndrome

    Aging and disease

More on Telomerase activity

Upstream

2

Prediabetes

no changein humans1

1 study
  1. Prediabetes were not clearly linked with acute coronary syndrome in humans after 1:1 propensity score matching.

    “The general association between prediabetes and ACS is similar to that in individuals with normal glycemic status.”

    Humansafter 1:1 propensity score matching

    The Association Between Glycemic Disorders and Acute Coronary Syndrome: Plaque Vulnerability in Perimenopausal and Post-Menopausal Women With Diabetes

    British journal of hospital medicine (London, England : 2005)

More on Prediabetes

Irisin

no changein humans1OR 1

1 study
  1. Irisin was not clearly linked with acute coronary syndrome in otherwise healthy individuals (OR 1.00, 95% CI 0.99-1.00).

    “there was no association between irisin levels and ACS in otherwise healthy individuals (odds ratio: 1.00 95% confidence interval: (0.99-1.00)).”

    Humansin otherwise healthy individuals

    Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events

    International journal of obesity (2005)

More on Irisin

Associations

74

Air pollution

upin humans3

3 studies
  1. Air pollution is linked with a higher risk of acute coronary syndrome in humans.

    “All air pollutants analyzed increase the number of ACS hospital admission in the five locations evaluated.”

    Humans

    Environmental gaseous pollutants are related to increase of acute coronary syndrome in Valencia region, Spain

    Medicina clinica

  2. Air pollution is linked with a higher risk of acute coronary syndrome in humans (non-continuously vaccinated elderly population).

    “Increases in air pollution concentrations of CO, NO2, PM10 or PM2.5 and decreases in temperature significantly influenced the risk of ACS for the non-continuously vaccinated elderly population”

    Humansnon-continuously vaccinated elderly population3days prior to the ACS diagnosis daten = 1,128

    Influenza vaccination and the endurance against air pollution among elderly with acute coronary syndrome

    Vaccine

  3. Air pollution raises the risk of acute coronary syndrome in humans.

    “Air pollution also significantly affects the incidence of acute coronary syndromes through both short- and long-term exposure.”

    Review

    Air pollution and cardiovascular diseases. Opinion and recommendations of experts from the Prevention and Epidemiology Section of the Polish Cardiac Society

    Kardiologia polska

More on Air pollution

Major adverse cardiovascular events

upin humans2+42%

2 studies
  1. Acute coronary syndrome is associated with major adverse cardiovascular events in humans (ACS patients undergoing coronary angiography) (42%).

    “In all, 42% of the patients had MACEs and 25% had post-ACS heart failure.”

    HumansACS patients undergoing coronary angiography

    Long-term major adverse cardiovascular events and quality of life after coronary angiography in elderly patients with acute coronary syndrome

    International journal of cardiology

  2. Acute coronary syndrome is associated with major adverse cardiovascular events in humans after acute coronary syndrome (Overall 90-day MACE rate of 4.1%; nearly half of first-year adverse events occur within 90 days).

    “Post-ACS MACE clusters within 90 days after discharge.”

    Reviewafter acute coronary syndrome90 days after discharge

    MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ACUTE CORONARY SYNDROME: DEFINITION, TIMING, RATES, MAIN RISK FACTORS, AND WAYS TO IMPROVE

    Georgian medical news

Lipoprotein

mixedin humans1upin humans1HR 2.04

2 studies
  1. Acute coronary syndrome is associated with lipoprotein in humans following acute coronary syndrome (+30.0% at Days 4–7; +15.0% at Day 30; return to baseline at follow-up).

    “Lp(a) increased following ACS (p < 0.001), peaking at Days 4-7 (+30.0 %, p = 0.0001)”

    Humansfollowing acute coronary syndrome≥6 monthsn = 225

    Temporal changes in lipoprotein(a) after acute coronary syndrome

    American journal of preventive cardiology

  2. Lipoprotein is linked with a higher risk of acute coronary syndrome in humans (high versus low Lp(a) groups (>50 mg/dl vs <30 mg/dl) adjusted for age and BMI) (HR 2.04 (95% CI, 1.0-4.2; P = 0.05)).

    “the hazard ratio was 2.04 (95% CI, 1.0-4.2; P = 0.05) in the high versus low Lp(a) groups”

    Humanshigh versus low Lp(a) groups (>50 mg/dl vs <30 mg/dl) adjusted for age and BMIup to 8 yearsmalesn = 755

    Elevated lipoprotein(a) as a predictor for coronary events in older men

    Journal of lipid research

More on Lipoprotein

Telomere length

upin humans1downin humans1OR 1.87

2 studies
  1. Telomere length is linked with a higher risk of acute coronary syndrome in humans (carriers of shorter telomeres, per 1 LTL decile) (adjusted OR=1.87 (95% CI 1.70-2.06)).

    “The carriers of shorter telomeres had increased 15-year risk of MI/ACS with adjusted OR=1,87 (95% CI 1,70-2,06) per 1 LTL decile independent of other factors.”

    Humanscarriers of shorter telomeres, per 1 LTL decileleukocytes15 years

    The relationship between the relative length of leukocyte telomeres and mtDNA copy number and acute coronary syndrome in a 15-year follow-up

    Advances in gerontology = Uspekhi gerontologii

  2. Acute coronary syndrome is associated with telomere length in humans (before multiple adjustments) (P<0.001).

    “We detected significantly shorter LTL in women with ACS (P<0.001), but the difference disappeared after multiple adjustments.”

    Humansbefore multiple adjustmentsfemales

    Genetic variants within telomere-associated genes, leukocyte telomere length and the risk of acute coronary syndrome in Czech women

    Clinica chimica acta; international journal of clinical chemistry

More on Telomere length

Noncalcified plaque volume

upin humans1HR 5.11

1 study
  1. Noncalcified plaque volume predicts acute coronary syndrome in humans (noncalcified plaque volume ≥32 mm3) (Patient-level adjusted HR 5.11, 95% CI 2.49–10.46).

    “NCPV ≥32 mm3: adjusted HR: 5.11; 95% CI: 2.49-10.46; P < 0.001) with consistent results in the validation cohort.”

    Humansnoncalcified plaque volume ≥32 mm3coronary artery

    Characteristics and Thresholds of Coronary Lesions to Predict Acute Coronary Syndrome From Artificial Intelligence-Guided Coronary Computed Tomography Angiography

    JACC. Cardiovascular imaging

More on Noncalcified plaque volume

Total plaque volume

upin humans1HR 2.92

1 study
  1. Total plaque volume predicts acute coronary syndrome in humans (total plaque volume ≥55 mm3) (Patient-level adjusted HR 2.92, 95% CI 1.65–5.16).

    “patient-level ACS (TPV ≥55 mm3: adjusted HR: 2.92; 95% CI: 1.65-5.16; P < 0.001;”

    Humanstotal plaque volume ≥55 mm3coronary artery

    Characteristics and Thresholds of Coronary Lesions to Predict Acute Coronary Syndrome From Artificial Intelligence-Guided Coronary Computed Tomography Angiography

    JACC. Cardiovascular imaging

More on Total plaque volume

Age

upin humans1OR 1.02

1 study
  1. Age predicts acute coronary syndrome in humans (OR 1.02; 95% CI 1.02-1.03).

    “age (OR 1.02; 95% CI 1.02-1.03; p<0.001)”

    Humans26.8±14.5 monthsn = 60,000

    PHOENIX AI: A Multimodal Foundation Model for Coronary Plaque Phenotyping and Prediction of Future Acute Coronary Syndrome Using Coronary CT Angiography, A Global Multicenter Retrospective Study

    AHA Scientific Sessions 2026 abstract

C-reactive protein

upin humans1OR 1.06

1 study
  1. C-reactive protein predicts acute coronary syndrome in humans (OR 1.06; 95% CI 1.03-1.09).

    “hs-CRP (OR 1.06; 95% CI 1.03-1.09; p<0.001)”

    Humans26.8±14.5 monthsn = 60,000

    PHOENIX AI: A Multimodal Foundation Model for Coronary Plaque Phenotyping and Prediction of Future Acute Coronary Syndrome Using Coronary CT Angiography, A Global Multicenter Retrospective Study

    AHA Scientific Sessions 2026 abstract

More on C-reactive protein

Napkin-ring sign

upin humans1OR 3.35

1 study
  1. Napkin-ring sign predicts acute coronary syndrome in humans (OR 3.35; 95% CI 3.05-3.67).

    “napkin ring sign (OR 3.35; 95% CI 3.05-3.67; p<0.001)”

    Humans26.8±14.5 monthsn = 60,000

    PHOENIX AI: A Multimodal Foundation Model for Coronary Plaque Phenotyping and Prediction of Future Acute Coronary Syndrome Using Coronary CT Angiography, A Global Multicenter Retrospective Study

    AHA Scientific Sessions 2026 abstract

More on Napkin-ring sign

Positive remodeling

upin humans1OR 9.29

1 study
  1. Positive remodeling predicts acute coronary syndrome in humans (OR 9.29; 95% CI 6.38-13.53).

    “as did positive remodeling (OR 9.29; 95% CI 6.38-13.53; p<0.001)”

    Humans26.8±14.5 monthsn = 60,000

    PHOENIX AI: A Multimodal Foundation Model for Coronary Plaque Phenotyping and Prediction of Future Acute Coronary Syndrome Using Coronary CT Angiography, A Global Multicenter Retrospective Study

    AHA Scientific Sessions 2026 abstract

More on Positive remodeling

Twice-weekly portable electrocardiogram screening

downin humans1

1 study
  1. Twice-weekly portable electrocardiogram screening lowers the risk of acute coronary syndrome in humans (10 vs. 21).

    “Participants in the iECG care group were less likely to have an acute coronary syndrome event during the follow-up period than in the RC group (10 vs. 21, P = 0.044; ).”

    Human trial4.2 yearsn = 997

    Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study

    European heart journal open

More on Twice-weekly portable electrocardiogram screening

All 74

Trial sponsors

Funding

5 grants since 2018

National Heart, Lung, and Blood Institute$4.4MJapan Society for the Promotion of Science¥4.3MSwiss National Science Foundation

Latest

Dec 2025: 8Jan 2026: 25Feb 2026: 38Mar 2026: 35Apr 2026: 3May 2026: 10Jun 2026: 7Jul 2026: 15Aug 2026: 17Sep 2026: 19Oct 2026: 89Nov 2026: 36302 papers in 12 months

See all 727 papers on acute coronary syndrome